ARCHIVES

Technology Isolates and Recovers Circulating Liver Tumor Cells

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996

NCI To Merge Two Intramural Divisions To Form Center For Cancer Research.

January 12, 2001

Clearinghouse Completes Review of Backlog, Funds What Caused It, Reports On Program Value

May 19, 1978

NIH Carcinogen Guidelines Offered

April 24, 1981

Healy ‘Concerned’ About NCI Budget; ‘Definite Erosion’

May 3, 1991